Intact Vascular Announces Completion of Enrollment of the Tack Optimized Balloon Angioplasty (TOBA) Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the completion of enrollment of the Tack Optimized Balloon Angioplasty (TOBA) study. The purpose of this multi-center study is to gather confirmatory data on the use of the Tack-It Endovascular System™ in the superficial femoral and popliteal arteries.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC